ATS 2024 Final Program

Click on the session title to view the speakers

112

SUNDAY • MAYs 19

405 Positional Therapy for the Treatment of Positional Obstructive Sleep Apnea in Children: A Randomized Controlled Crossover Trial 406 A Multi-disciplinary Quality Improvement Initiative to Improve Timely Access to a Pediatric Tertiary Care Sleep Centre 407 Endothelial Dysfunction in Obstructive Sleep Apnea in Children and Adolescents 408 The Association Between Insomnia and Positive Airway Pressure Adherence in Children 409 Sleep in People With Cystic Fibrosis 410 Outcomes of Patients With CCHS Ventilated by Diaphragm Pacing 411 The Radiographic Assessment of Lung Edema (RALE) Score Is Associated With Impaired Oxygenation and Inflammatory Biomarkers in Pediatric Acute Respiratory Failure 412 The Association Between the End-tidal Alveolar Dead Space Fraction and Delirium in Pediatric ARDS 413 Tracheal Aspirates of Mechanically Ventilated Preterm Infants Possess Cytopathic Tau Variants 414 Managing Chronic Respiratory Failure in Severe Bronchopulmonary Dysplasia (SBPD): Using a Volume-targeted Approach in the Outpatient Setting 415 A Quality Improvement Intervention Targeting Reduction of Unplanned Tracheostomy Dislodgement in Hospitalized Children 416 Healthcare Utilization and Costs in Children Receiving Home Mechanical Ventilation: A 14-year Cohort Study 417 Role of Socioeconomic Impact on Frequency of Emergency Department Visits and Hospital Readmission Rates in Children Discharged on Home Mechanical Ventilation 418 Managing Severe Bronchopulmonary Dysplasia With Tracheostomy and Chronic Ventilation Using Volume Assured Pressure Support 419 Improving Utilization of Outpatient Tracheostomy and Ventilator Action Plans in the Pediatric Population

420 Nocturnal Blood Pressure Alterations in Pediatric Patients With Obstructive Sleep Apnea Measured by 24h Ambulatory Blood Pressure Monitoring

BASIC • CLINICAL • TRANSLATIONAL POSTER DISCUSSION SESSION

A107 INFECTIONS IN THE

IMMUNOSUPPRESSED AND IMMUNOCOMPROMISED HOST

2:15 p.m. - 4:15 p.m.

San Diego Convention Center Room 11A-B (Upper Level)

Poster Viewing

2:15-3:00 3:00-4:15

Discussion

501 Frequency, Duration, and Risk Factors for Diagnostic Delays Associated With Blastomycosis 502 Development of a Clinical Risk Score for the Prediction of Pneumocystis Jirovecii Pneumonia in Hospitalised Patients 503 Effectiveness of Pulse Methylprednisolone for Pneumocystis Pneumonia in Non-human Immunodeficiency Virus-infected Patients: A Multicenter, Retrospective Registry-based Cohort Study (RE-VISION-PCP) 504 Utility of Immunocap ® Specific Aspergillus IgG Assay for Diagnosis of Chronic Pulmonary Aspergillosis 505 Long Non-coding RNA Taurine Upregulated 1 (TUG1) Regulation of PGC-1 Alpha Expression Results in Altered Mitochondrial Bioenergetics in HIV-1 Infected Macrophages 506 Mortality and Lung Allograft Outcomes in Lung Transplant Recipients With COVID-19 Within the First Year Post-Transplant 507 Comparative Analysis of Cell Profiles and Diagnostic Yield in Bronchoalveolar Lavage Fluid of Neutropenic and Non-neutropenic Patients 508 Effect of Zinc on Mitochondrial Homeostasis in Macrophage Immune Function 509 Immunocompromised Hosts Hospitalized With

Community-acquired Pneumonia: Estimated Incidence and Mortality in the United States

ATS 2024 Conference Program • San Diego, CA